Living With the Threat of Clostridioides Difficile (C. Difficile) Infection?
Discover A New Path to Wellness Through C. Difficile Infection Clinical Trials
C. difficile is a serious bacterial infection that often develops after antibiotic use, leading to severe diarrhea, abdominal pain, and life-threatening complications. It is one of the most urgent antibiotic-resistant threats, impacting both hospital and community populations.
Revive Research Institute is conducting Clostridium Difficile Clinical Trials to explore investigational vaccine options that may help prevent infection and recurrence. This study is designed to evaluate the safety and effectiveness of a potential vaccine aimed at reducing the burden of C. difficile, which can cause recurrent and severe illness.
Are You Eligible to Participate?
To be eligible for C. diff clinical trials in Michigan, participants must:
- Be 50 years of age or older
- Have recent risk factors such as prior hospitalizations, frequent outpatient or emergency visits
*Additional criteria may apply.
Participation in Clostridium Difficile Infection Clinical Trials in Michigan may provide access to expert care, study-related monitoring, and investigational vaccines at no cost. Insurance is not required.